Grown Rogue International (GRUSF) Enterprise Value Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Enterprise Value Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -180.60% |
| Jul 31, 2023 | -121.33% |
| Apr 30, 2023 | -69.71% |
| Jan 31, 2023 | -83.80% |
| Oct 31, 2022 | 236.86% |
| Jan 31, 2022 | -27.94% |
| Oct 31, 2021 | 50.20% |
| Apr 30, 2021 | -52.45% |
| Oct 31, 2020 | 17.86% |
| Aug 31, 2018 | 24.41% |
| May 31, 2018 | -4,843.32% |
| Feb 28, 2018 | -6.37% |
| Nov 30, 2017 | 18.07% |
| Aug 31, 2017 | 79.62% |
| May 31, 2017 | 78.64% |
| Feb 28, 2017 | 48.90% |
| Nov 30, 2016 | -11.99% |
| Aug 31, 2016 | -22.26% |
| May 31, 2016 | 7.63% |
| Feb 29, 2016 | 61.96% |